MedPath

Desmopressin nasal spray to decrease the bleeding complications in percutaneous kidney biopsy

Phase 2
Conditions
Health Condition 1: N17-N19- Acute kidney failure and chronic kidney diseaseHealth Condition 2: N00-N08- Glomerular diseasesHealth Condition 3: N10-N16- Renal tubulo-interstitial diseases
Registration Number
CTRI/2020/12/029747
Lead Sponsor
Department of Nephrology INHS Asvini
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Blood pressure < 140/90 mmHg

2. Normal coagulation parameters and platelet count

Exclusion Criteria

Graft kidney biopsy, Patients on antiplatelets, Poorly controlled hypertension, Hydro/pyonephrosis, Any form of coagulation disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath